CYPROTERONE ASCENT 100 cyproterone acetate 100mg tablet bottle

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

cyproterone acetate, Quantity: 100 mg

Disponible des:

Medis Pharma Pty Ltd

Designació comuna internacional (DCI):

cyproterone acetate

formulario farmacéutico:

Tablet, uncoated

Composición:

Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; povidone; magnesium stearate

Vía de administración:

Oral

Unidades en paquete:

50 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Inoperable prostatic carcinoma. To suppress flare with initial luteinising hormone releasing hormone (LHRH) analogue therapy; in long-term palliative treatment where LHRH analogues or surgery are ineffective, not tolerated, contraindicated or where oral therapy is preferred; in the treatment of hot flushes in patients treated with LHRH analogues or who have had orchidectomy.

Resumen del producto:

Visual Identification: White to off white, capsule shaped tablet with '100' engraved on one face, and a break line on the other face.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Estat d'Autorització:

Licence status A

Data d'autorització:

2012-05-23